Aethlon medical to present at the 13th annual ld micro invitational

San diego , june 1, 2023 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases, today announced that guy cipriani, senior vice president and chief business officer, and james frakes, chief financial officer, will present a company overview at the 13th annual ld micro invitational on wednesday, june 7, 2023, at 1:30 pm pt. management will also be participating in one-on-one meetings with investors at this conference being held june 6-8, 2023, in los angeles, california.
AEMD Ratings Summary
AEMD Quant Ranking